San Diego, CA -- (SBWIRE) -- 02/12/2018 -- MabVax Therapeutics Holdings, Inc is under investigation over potential violations of securities laws in connection with certain statements made by MabVax Therapeutics Holdings, Inc.

Investors who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether a series of statements by MabVax Therapeutics Holdings, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On January 30, 2018, MabVax Therapeutics Holdings, Inc. announced "that it received notice that the Securities and Exchange Commission ("SEC") was conducting an investigation and examination pursuant to Section 8(e) of the Securities Act of 1933, as amended, relating to certain of the Company's registration statements (and amendments thereto)."

Those who purchased shares of MabVax Therapeutics Holdings, Inc. (NASDAQ:MBVX) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com